ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

PHBI Pharmagreen Biotech Inc (PK)

0.0009
0.00015 (20.00%)
07 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Pharmagreen Biotech Inc (PK) USOTC:PHBI OTCMarkets Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00015 20.00% 0.0009 0.0006 0.001 0.0009 0.0007 0.0008 210,961 21:03:00

Termination of Registration of a Class of Security Under Section 13 and 15(d) (15-15d)

03/02/2017 7:46pm

Edgar (US Regulatory)


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 15

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(G) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number 333-151350

Air Transport Group Holdings, Inc.
(Exact name of registrant as specified in its charter)

7453 Woodruff Way, Stone Mountain, Georgia 30087
604-773-0242

(Address, including zip code, and telephone number, including area code, of registrant's principal executive offices)

Common
(Title of each class of securities covered by this Form)

None

(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

Rule 12g-4(a)(1)         [X]
Rule 12g-4(a)(2)         [ ]
Rule 12h-3(b)(1)(i)      [X]
Rule 12h-3(b)(1)(ii)     [ ]
Rule 15d-6               [ ]
Rule 15d-22(b)           [ ]

Approximate number of holders of record as of the certification or notice date:
26

Pursuant to the requirements of the Securities Exchange Act of 1934 (Name of registrant as specified in charter) has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

Date: February 3, 2017                   By: /s/ Shawn Balaghi
                                            ------------------------------------
                                         Name:   Shawn Balaghi
                                         Title:  President

1 Year Pharmagreen Biotech (PK) Chart

1 Year Pharmagreen Biotech (PK) Chart

1 Month Pharmagreen Biotech (PK) Chart

1 Month Pharmagreen Biotech (PK) Chart

Your Recent History

Delayed Upgrade Clock